Aarti Industries Ltd · NSE:AARTIIND
Aarti Industries — Q3 FY2019 Earnings Presentation
17 slides from Aarti Industries's earnings presentation, Feb 4, 2019
Slide 1: Cover letter to stock exchanges
AARTI @l INDUSTRIES LIMITED Ref. No.: AII/B-38 l20l9l L22 February 4,2OL9 To, To, Listing/ Compliance Department Listing/ Compliance Department BSE LTD. National Stock Exchange of Phiroze Jeejeebhoy Towers, India Limited Dalal Street, "Exchange Plaza", Plot No. Cll, Mumbai - 4OO OO 1. G Block Bandra
Slide 2: Q3 & 9M FY19 Results Presentation
Q3 & 9M FY19 Results Presentation
Slide 3: Disclaimer
Disclaimer AARTI INDUSTRIES LIMITED may, from time to time, make written and oral forward looking statements, in addition to statements contained in the company's filings with BSE Limited [BSE] and National Stock Exchange of India Limited [NSE], and our reports to shareholders. The company does not
Slide 4: Agenda
Agenda 1 | At a glance 2 | Quarterly performance 3 | 5 year financial performance 3
Slide 5: Company Profile: At a glance
Company Profile: At a glance Established in 1984 & listed on Indian stock exchange in 1992 Chemicals Polymer & additives Five of six Promoter Directors have engineering background. Three of four Founder Promoters are chemical engineers from Agrochemicals & intermediates ICT (formerly known a
Slide 6: Agenda
Agenda 1 | At a glance 2 | Quarterly performance 3 | 5 year financial performance 5
Slide 7: Chairman's Message
Chairman’s Message Commenting on the performance for Q3 & 9M FY19, Mr. Rajendra Gogri – Chairman & MD at Aarti Industries Ltd. said, “We have delivered another strong performance during Q3, recording revenue growth of 28% and expanding EBITDA, which led to profits increasing by 48%. Growth was drive
Slide 8: Q3 FY19 Highlights
Q3 FY19 Highlights Financial & Capex Strong improvement in revenue and margins across Speciality Chemicals and Pharma segments EBIT margin expands 180 bps YoY to 16.3% in Q3 FY19. As part of its strategy to safeguard business against currency risks, the Company had entered into forward contrac
Slide 9: Q3 & 9M FY19 P&L (Standalone)
Q3 & 9M FY19 P&L (Standalone) Y-o-Y Y-o-Y Particulars 9M FY19 9M FY18 Growth Q3 FY19 Q3 FY18 Growth (Rs. Crore) (%) (%) Gross Income from Operations 3,646.15 2,669.92 36.6% 1,268.15 990.22 28.1% Exports 1,371.72 1,192.07 15.1% 504.27 471.37 7.0% • Expanding contribution of higher value products and
Slide 10: Q3 & 9M FY19 – Speciality Chemicals (Standalone)
Q3 & 9M FY19 – Speciality Chemicals (Standalone) Higher capacity utilization across various units Revenue EBIT margins expand to 20.7% in Q3 FY19 from 19.4% in Q3 FY18 2902 Continuing geographical shift in production to 2091 India leading to higher demand even from 1014 domestic end-users . 77
Slide 11: Q3 & 9M FY19 – Pharma & HPC (Standalone)
Q3 & 9M FY19 – Pharma & HPC (Standalone) Pharmaceuticals Revenue Pharmaceuticals EBIT 513 85 EBIT margin expansion continues 382 Expanding business volumes across markets and operating 49 leverage. 171 30 139 Focusing on off‐patented generics to be supplied in regulated 17 markets Q3 FY18 Q3 F
Slide 12: Agenda
Agenda 1 | At a glance 2 | Quarterly performance 3 | 5 year financial performance 11
Slide 13: Revenue Performance (Consolidated)
Revenue Performance (Consolidated) Operating revenues have Revenue Export Deep engagement with grown on the back of strong CAGR: 9.7% global customers in Speciality volume growth in key 1,523 1,596 chemicals and pharma. In 1,449 1,431 business segments and 1,281 addition, part of domestic better pro
Slide 14: EBIT Performance (Consolidated)
EBIT Performance (Consolidated) Higher growth relative to revenue EBIT highlights value addition CAGR: 15.9% 660 615 delivered by AIL 542 447 366 FY14 FY15 FY16 FY17 FY18 Speciality Chemicals Pharmacuticals Home & Personal Care CAGR: 14% CAGR: 27.4% 566 578 504 79 4 408 3 3 333 48 36 39 30 1 (0) FY1
Slide 15: Financial Highlights – (Consolidated)
Financial Highlights – (Consolidated) EBITDA & Net Profit (Rs. Cr.) 316 331 257 206 162 401 466 572 653 707 FY14 FY15 FY16 FY17 FY18 EBITDA Net Profit Earnings Per Share (EPS) 38.45 40.65 30.83 23.24 18.34 FY14 FY15 FY16 FY17 FY18 14
Slide 16: Contact Us
Contact Us For further information please log on to www.aarti-industries.com or contact: Mr. Chetan Gandhi / Mr. Raj Sarraf Aarti Industries Limited Tel: +91 22 6797 6666 Email: info@aarti-industries.com Shiv Muttoo / Varun Divadkar CDR India Tel: +91 22 6645 1207/ 97637 02204 Email: shiv@cdr-india.
Slide 17: Thank You
@® AARTI INDUSTRIES LIMITED 4 SLRs UL LS PRODUCTIVITY WITH SAFETY IS OUR MOTTO =